Search
CytomX Therapeutics Inc
CTMXAdd to Watchlist
2.950USD
0.0000.00%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
502.05MMarket Cap
LossP/E TTM
CytomX Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of CytomX Therapeutics Inc is 7.83, ranking 195 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -5.67, which is -530.34% below the recent high of 24.38 and -6172.20% above the recent low of -355.38.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
